Publications by authors named "Anna Svirina"

Article Synopsis
  • Human norovirus, a major cause of acute gastroenteritis outbreaks, lacks approved vaccines or antivirals, but recent research on norovirus inhibitors like monoclonal antibodies (Mabs) and nanobodies shows promise in blocking virus replication.
  • The study focused on enhancing a cross-reactive nanobody (NB26) by conjugating it with a human IgG Fc domain to create Fc-NB26, which displayed significantly improved binding and neutralization capabilities against various norovirus strains.
  • The findings indicate that structural modifications to nanobodies not only heighten their efficacy but also offer potential pathways for developing broad-spectrum therapeutics against the evolving norovirus landscape.
View Article and Find Full Text PDF

Poorly immunogenic small molecules pose challenges for the production of clinically efficacious vaccines and antibodies. To address this, we generate an immunization platform derived from the immunogenic surface coat of the African trypanosome. Through sortase-based conjugation of the target molecules to the variant surface glycoprotein (VSG) of the trypanosome surface coat, we develop VSG-immunogen array by sortase tagging (VAST).

View Article and Find Full Text PDF

Outer membrane proteins (OMPs) maintain the viability of Gram-negative bacteria by functioning as receptors, transporters, ion channels, lipases, and porins. Folding and assembly of OMPs involves synchronized action of chaperones and multi-protein machineries which escort the highly hydrophobic polypeptides to their target outer membrane in a folding competent state. Previous studies have identified proteins and their involvement along the OMP biogenesis pathway.

View Article and Find Full Text PDF

Periplasmic chaperones 17-kilodalton protein (Skp) and survival factor A (SurA) are essential players in outer membrane protein (OMP) biogenesis. They prevent unfolded OMPs from misfolding during their passage through the periplasmic space and aid in the disassembly of OMP aggregates under cellular stress conditions. However, functionally important links between interaction mechanisms, structural dynamics, and energetics that underpin both Skp and SurA associations with OMPs have remained largely unresolved.

View Article and Find Full Text PDF

Membrane-active peptides that demonstrate cell-penetrating, antimicrobial or cytotoxic functions are diverse in their amino acid sequences, but share common physicochemical features like short length, amphipathic conformation in membrane environment and high net charge. Nonspecific electrostatic interactions of basic peptide residues with anionic membrane lipids play a crucial role in the initial binding of such peptides to plasma membranes of bacterial and mammalian cells. At the same time, a number of membrane-active peptides functions when they are localized at high concentrations on the lipid membranes.

View Article and Find Full Text PDF

: The ability of ErbB3 receptor to functionally complement ErbB1-2 and induce tumor resistance to their inhibitors makes it a unique target in cancer therapy by monoclonal antibodies. Here we report the expression, purification and structural analysis of a new anti-ErbB3 single-chain antibody. : The VHH fragment of the antibody was expressed in cells as a SUMO fusion, cleaved by TEV protease and purified to homogeneity.

View Article and Find Full Text PDF